For any grade AEs, hematological AEs, such as anemia and neutropenia, and gastrointestinal reactions, such as nausea, decreased appetite, and diarrhea, were all significantly less common with anti-PD-1/PD-L1 therapy. This evidence concerns the gene CD274 and anemia (phenotype).